Elevated Levels of T Helper 17 Cells Are Associated with Disease Activity in Patients with Rheumatoid Arthritis

Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We aimed to investigate the distribution of Th1 and Th17 cells and their association with disease activity, and determine the Th17-related cytokin...

Full description

Saved in:
Bibliographic Details
Published inAnnals of laboratory medicine Vol. 33; no. 1; pp. 52 - 59
Main Authors Kim, Jimyung, Kang, Seongwook, Kim, Jinhyun, Kwon, Gyechul, Koo, Sunhoe
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society for Laboratory Medicine 01.01.2013
대한진단검사의학회
Subjects
Online AccessGet full text
ISSN2234-3806
2234-3814
2234-3814
DOI10.3343/alm.2013.33.1.52

Cover

Abstract Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We aimed to investigate the distribution of Th1 and Th17 cells and their association with disease activity, and determine the Th17-related cytokine levels in the peripheral blood of RA patients. Peripheral blood mononuclear cells from 55 RA and 20 osteoarthritis (OA) patients were stimulated with mitogen, and the distributions of CD4(+)Interferon (INF)(+)IL-17(-) (Th1 cells) and CD4(+)INF-IL-17(+) (Th17 cells) were examined by flow cytometry. Serum levels of IL-6, IL-17, IL-21, IL-23, and tumor necrosis factor (TNF)-α were measured by ELISA. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were recorded. The 28-joint disease activity score (DAS28) was also assessed. The median percentage of Th17 cells was higher in RA patients than in OA patients (P=0.04), and in active than in inactive RA (P=0.03), whereas that of Th1 cells was similar in both groups. Similarly, the levels of IL-17, IL-21, and IL-23 were detected in a significantly higher proportion of RA patients than OA patients and the frequencies of detectable IL-6, IL-17, and IL-21 were higher in active RA than in inactive RA group. The percentage of Th17 cells positively correlated with the DAS28, ESR, and CRP levels. These observations suggest that Th17 cells and Th17-related cytokines play an important role in RA pathogenesis and that the level of Th17 cells in peripheral blood is associated with disease activity in RA.
AbstractList Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We aimed to investigate the distribution of Th1 and Th17 cells and their association with disease activity, and determine the Th17-related cytokine levels in the peripheral blood of RA patients.BACKGROUNDInterleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We aimed to investigate the distribution of Th1 and Th17 cells and their association with disease activity, and determine the Th17-related cytokine levels in the peripheral blood of RA patients.Peripheral blood mononuclear cells from 55 RA and 20 osteoarthritis (OA) patients were stimulated with mitogen, and the distributions of CD4(+)Interferon (INF)(+)IL-17(-) (Th1 cells) and CD4(+)INF-IL-17(+) (Th17 cells) were examined by flow cytometry. Serum levels of IL-6, IL-17, IL-21, IL-23, and tumor necrosis factor (TNF)-α were measured by ELISA. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were recorded. The 28-joint disease activity score (DAS28) was also assessed.METHODSPeripheral blood mononuclear cells from 55 RA and 20 osteoarthritis (OA) patients were stimulated with mitogen, and the distributions of CD4(+)Interferon (INF)(+)IL-17(-) (Th1 cells) and CD4(+)INF-IL-17(+) (Th17 cells) were examined by flow cytometry. Serum levels of IL-6, IL-17, IL-21, IL-23, and tumor necrosis factor (TNF)-α were measured by ELISA. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were recorded. The 28-joint disease activity score (DAS28) was also assessed.The median percentage of Th17 cells was higher in RA patients than in OA patients (P=0.04), and in active than in inactive RA (P=0.03), whereas that of Th1 cells was similar in both groups. Similarly, the levels of IL-17, IL-21, and IL-23 were detected in a significantly higher proportion of RA patients than OA patients and the frequencies of detectable IL-6, IL-17, and IL-21 were higher in active RA than in inactive RA group. The percentage of Th17 cells positively correlated with the DAS28, ESR, and CRP levels.RESULTSThe median percentage of Th17 cells was higher in RA patients than in OA patients (P=0.04), and in active than in inactive RA (P=0.03), whereas that of Th1 cells was similar in both groups. Similarly, the levels of IL-17, IL-21, and IL-23 were detected in a significantly higher proportion of RA patients than OA patients and the frequencies of detectable IL-6, IL-17, and IL-21 were higher in active RA than in inactive RA group. The percentage of Th17 cells positively correlated with the DAS28, ESR, and CRP levels.These observations suggest that Th17 cells and Th17-related cytokines play an important role in RA pathogenesis and that the level of Th17 cells in peripheral blood is associated with disease activity in RA.CONCLUSIONSThese observations suggest that Th17 cells and Th17-related cytokines play an important role in RA pathogenesis and that the level of Th17 cells in peripheral blood is associated with disease activity in RA.
Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We aimed to investigate the distribution of Th1 and Th17 cells and their association with disease activity, and determine the Th17-related cytokine levels in the peripheral blood of RA patients. Peripheral blood mononuclear cells from 55 RA and 20 osteoarthritis (OA) patients were stimulated with mitogen, and the distributions of CD4(+)Interferon (INF)(+)IL-17(-) (Th1 cells) and CD4(+)INF-IL-17(+) (Th17 cells) were examined by flow cytometry. Serum levels of IL-6, IL-17, IL-21, IL-23, and tumor necrosis factor (TNF)-α were measured by ELISA. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were recorded. The 28-joint disease activity score (DAS28) was also assessed. The median percentage of Th17 cells was higher in RA patients than in OA patients (P=0.04), and in active than in inactive RA (P=0.03), whereas that of Th1 cells was similar in both groups. Similarly, the levels of IL-17, IL-21, and IL-23 were detected in a significantly higher proportion of RA patients than OA patients and the frequencies of detectable IL-6, IL-17, and IL-21 were higher in active RA than in inactive RA group. The percentage of Th17 cells positively correlated with the DAS28, ESR, and CRP levels. These observations suggest that Th17 cells and Th17-related cytokines play an important role in RA pathogenesis and that the level of Th17 cells in peripheral blood is associated with disease activity in RA.
Background: Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We aimed to investigate the distribution of Th1 and Th17 cells and their association with disease activity, and determine the Th17-related cytokine levels in the peripheral blood of RA patients. Methods: Peripheral blood mononuclear cells from 55 RA and 20 osteoarthritis (OA) patients were stimulated with mitogen, and the distributions of CD4+Interferon (INF)+IL-17-(Th1 cells) and CD4+INF-IL-17+ (Th17 cells) were examined by flow cytometry. Serum levels of IL-6, IL-17, IL-21, IL-23, and tumor necrosis factor (TNF)-α were measured by ELISA. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were recorded. The 28-joint disease activity score (DAS28) was also assessed. Results: The median percentage of Th17 cells was higher in RA patients than in OA patients (P =0.04), and in active than in inactive RA (P =0.03), whereas that of Th1 cells was similar in both groups. Similarly, the levels of IL-17, IL-21, and IL-23 were detected in a significantly higher proportion of RA patients than OA patients and the frequencies of detectable IL-6, IL-17, and IL-21 were higher in active RA than in inactive RA group. The percentage of Th17 cells positively correlated with the DAS28, ESR, and CRP levels. Conclusions: These observations suggest that Th17 cells and Th17-related cytokines play an important role in RA pathogenesis and that the level of Th17 cells in peripheral blood is associated with disease activity in RA. KCI Citation Count: 33
Author Kang, Seongwook
Kim, Jimyung
Kim, Jinhyun
Kwon, Gyechul
Koo, Sunhoe
AuthorAffiliation 1 Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea
2 Department of Rheumatology, Chungnam National University College of Medicine, Daejeon, Korea
AuthorAffiliation_xml – name: 1 Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea
– name: 2 Department of Rheumatology, Chungnam National University College of Medicine, Daejeon, Korea
Author_xml – sequence: 1
  givenname: Jimyung
  surname: Kim
  fullname: Kim, Jimyung
  organization: Departments of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea
– sequence: 2
  givenname: Seongwook
  surname: Kang
  fullname: Kang, Seongwook
  organization: Departments of Rheumatology, Chungnam National University College of Medicine, Daejeon, Korea
– sequence: 3
  givenname: Jinhyun
  surname: Kim
  fullname: Kim, Jinhyun
  organization: Departments of Rheumatology, Chungnam National University College of Medicine, Daejeon, Korea
– sequence: 4
  givenname: Gyechul
  surname: Kwon
  fullname: Kwon, Gyechul
  organization: Departments of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea
– sequence: 5
  givenname: Sunhoe
  surname: Koo
  fullname: Koo, Sunhoe
  organization: Departments of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23301223$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001730163$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1UUtvEzEQtlARLaF3TshHLgl-7-4FKUoLrRQJVIWzNfHOEtPddbCdoP57nKStAAlfxjP-HvJ8r8nZGEYk5C1nMymV_AD9MBOMy9LN-EyLF-RCCKmmsubq7PnOzDm5TOkHK8cwLhr2ipwLKctVyAsSrnvcQ8aWLnGPfaKhoyt6g_0WI-UVXWBfhvOIdJ5ScP4I_eXzhl75hJDK3GW_9_mB-pF-hexxzOmEuNvgboAcfFsE8ib67NMb8rKDPuHlY52Qb5-uV4ub6fLL59vFfDl1SvM8rUEBYtNUErRpG1E1HVRtjW29VsCVBikB1nVViWaNXVszBka1qBrtjAFj5IS8P-mOsbP3ztsA_li_B3sf7fxudWu5ErI4TMjHE3S7Ww_YuvKBCL3dRj9AfDgS_34Z_abI7K3UUvOjwKPXNoafO0zZDj65sjgYMeyS5aIqgRkldIG--9Pr2eQpkAIwJ4CLIaWInXU-l62Gg7XvLWf2EL4t4dtD-KWz3GpRiOwf4pP2fym_ASaWsmU
CitedBy_id crossref_primary_10_1007_s00005_015_0344_z
crossref_primary_10_1016_j_ejr_2020_02_009
crossref_primary_10_1016_j_bcp_2020_113822
crossref_primary_10_1111_cei_12860
crossref_primary_10_2119_molmed_2015_00057
crossref_primary_10_1016_j_ejr_2014_06_004
crossref_primary_10_1302_2046_3758_117_BJR_2021_0594_R1
crossref_primary_10_1111_apm_12399
crossref_primary_10_1007_s10067_013_2476_z
crossref_primary_10_1016_j_intimp_2022_109271
crossref_primary_10_1093_rheumatology_kez587
crossref_primary_10_1080_14789450_2021_1908892
crossref_primary_10_1186_s13075_017_1349_2
crossref_primary_10_1016_j_yexmp_2021_104689
crossref_primary_10_3389_fimmu_2019_00798
crossref_primary_10_1089_bio_2022_0003
crossref_primary_10_1002_term_2958
crossref_primary_10_1016_j_vaccine_2018_04_062
crossref_primary_10_1155_2016_3507503
crossref_primary_10_1016_j_intimp_2015_12_011
crossref_primary_10_1038_nrrheum_2015_53
crossref_primary_10_1371_journal_pone_0164757
crossref_primary_10_1111_sji_13226
crossref_primary_10_1155_2015_487230
crossref_primary_10_4103_1110_161X_168164
crossref_primary_10_1371_journal_pone_0242092
crossref_primary_10_3390_ph17040465
crossref_primary_10_1016_j_lfs_2013_07_022
crossref_primary_10_1111_apm_12629
crossref_primary_10_3390_pharmaceutics14020404
crossref_primary_10_1007_s00296_013_2788_y
crossref_primary_10_1111_odi_14952
crossref_primary_10_1007_s11684_015_0388_9
crossref_primary_10_1038_s41392_023_01471_y
crossref_primary_10_1016_j_jaut_2016_02_008
crossref_primary_10_1002_clc_24065
crossref_primary_10_1007_s00018_021_04076_2
crossref_primary_10_1155_2015_751793
crossref_primary_10_3109_09273948_2015_1063672
crossref_primary_10_1189_jlb_3A0714_327R
crossref_primary_10_1080_08916934_2019_1631812
crossref_primary_10_1007_s00109_014_1232_4
crossref_primary_10_2217_epi_13_87
crossref_primary_10_1002_JLB_4RU0619_197R
crossref_primary_10_1111_sji_12197
crossref_primary_10_1186_s12929_022_00790_6
crossref_primary_10_1155_2013_203705
crossref_primary_10_1016_j_patbio_2015_04_004
crossref_primary_10_1016_j_mito_2023_10_004
crossref_primary_10_1007_s10067_019_04768_y
crossref_primary_10_1177_0022034521990652
crossref_primary_10_1155_2015_519638
Cites_doi 10.1186/ar3431
10.1002/art.21749
10.1080/03009740701286813
10.1038/ni0407-345
10.1016/S0140-6736(09)60008-8
10.1007/s10875-011-9540-8
10.1016/j.clim.2010.10.002
10.1186/ar2477
10.4049/jimmunol.179.3.1449
10.3899/jrheum.110697
10.1007/s12026-007-8014-9
10.1002/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E
10.1172/JCI5703
10.1111/j.1365-3083.2009.02361.x
10.1136/ard.2007.080341
10.1002/art.24568
10.1038/nri2094
10.1002/art.27622
10.1002/art.1780380107
10.1002/art.27186
10.1016/0009-9120(93)90032-2
10.1084/jem.183.6.2593
10.3343/kjlm.2010.30.3.301
10.3899/jrheum.100259
10.1038/ni1488
10.4049/jimmunol.160.7.3513
ContentType Journal Article
Copyright The Korean Society for Laboratory Medicine. 2013
Copyright_xml – notice: The Korean Society for Laboratory Medicine. 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.3343/alm.2013.33.1.52
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2234-3814
EndPage 59
ExternalDocumentID oai_kci_go_kr_ARTI_142397
PMC3535197
23301223
10_3343_alm_2013_33_1_52
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
5-W
53G
8JR
8XY
9ZL
AAYXX
ACYCR
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
C~G
DIK
DYU
EF.
GX1
HYE
KQ8
M48
PGMZT
RPM
CGR
CUY
CVF
ECGQY
ECM
EIF
EMOBN
M~E
NPM
OK1
7X8
5PM
ID FETCH-LOGICAL-c451t-8a4aee9973a56d9279fa7d8ed8b4a145a33aab87729befd800a64de495c66a663
IEDL.DBID M48
ISSN 2234-3806
2234-3814
IngestDate Sun Mar 09 07:53:59 EDT 2025
Thu Aug 21 14:30:52 EDT 2025
Thu Jul 10 18:19:27 EDT 2025
Thu Jan 02 22:14:06 EST 2025
Thu Apr 24 23:06:35 EDT 2025
Tue Jul 01 03:11:31 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Cytokines
T helper 17 cell
Rheumatoid arthritis
T helper 1 cell
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c451t-8a4aee9973a56d9279fa7d8ed8b4a145a33aab87729befd800a64de495c66a663
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000327.2013.33.1.008
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3343/alm.2013.33.1.52
PMID 23301223
PQID 1273346425
PQPubID 23479
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_142397
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3535197
proquest_miscellaneous_1273346425
pubmed_primary_23301223
crossref_citationtrail_10_3343_alm_2013_33_1_52
crossref_primary_10_3343_alm_2013_33_1_52
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-01-01
PublicationDateYYYYMMDD 2013-01-01
PublicationDate_xml – month: 01
  year: 2013
  text: 2013-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Annals of laboratory medicine
PublicationTitleAlternate Ann Lab Med
PublicationYear 2013
Publisher The Korean Society for Laboratory Medicine
대한진단검사의학회
Publisher_xml – name: The Korean Society for Laboratory Medicine
– name: 대한진단검사의학회
References Zivojinovic (10.3343/alm.2013.33.1.52_ref21) 2012; 39
Yamada (10.3343/alm.2013.33.1.52_ref10) 2008; 67
Zhang (10.3343/alm.2013.33.1.52_ref9) 2011; 31
McInnes (10.3343/alm.2013.33.1.52_ref2) 2007; 7
Shahrara (10.3343/alm.2013.33.1.52_ref18) 2008; 10
Rasmussen (10.3343/alm.2013.33.1.52_ref12) 2010; 37
Kang (10.3343/alm.2013.33.1.52_ref20) 2010; 30
Zhou (10.3343/alm.2013.33.1.52_ref13) 2007; 8
Iwamoto (10.3343/alm.2013.33.1.52_ref14) 2007; 179
Moore (10.3343/alm.2013.33.1.52_ref25) 1993; 26
Leipe (10.3343/alm.2013.33.1.52_ref23) 2010; 62
Bettelli (10.3343/alm.2013.33.1.52_ref8) 2007; 8
Kim (10.3343/alm.2013.33.1.52_ref16) 2007; 36
Fossiez (10.3343/alm.2013.33.1.52_ref5) 1996; 183
Kokkonen (10.3343/alm.2013.33.1.52_ref24) 2010; 62
Paradowska-Gorycka (10.3343/alm.2013.33.1.52_ref26) 2010; 71
Kirkham (10.3343/alm.2013.33.1.52_ref4) 2006; 54
Guedez (10.3343/alm.2013.33.1.52_ref3) 2001; 44
Kotake (10.3343/alm.2013.33.1.52_ref7) 1999; 103
Prevoo (10.3343/alm.2013.33.1.52_ref17) 1995; 38
Chen (10.3343/alm.2013.33.1.52_ref22) 2008; 41
Shen (10.3343/alm.2013.33.1.52_ref19) 2009; 60
Jovanovic (10.3343/alm.2013.33.1.52_ref6) 1998; 160
Klareskog (10.3343/alm.2013.33.1.52_ref1) 2009; 373
Zizzo (10.3343/alm.2013.33.1.52_ref11) 2011; 138
Chen (10.3343/alm.2013.33.1.52_ref15) 2011; 13
18710567 - Arthritis Res Ther. 2008;10(4):R93
7818570 - Arthritis Rheum. 1995 Jan;38(1):44-8
11665984 - Arthritis Rheum. 2001 Oct;44(10):2413-24
20112361 - Arthritis Rheum. 2010 Feb;62(2):383-91
17581537 - Nat Immunol. 2007 Sep;8(9):967-74
16572447 - Arthritis Rheum. 2006 Apr;54(4):1122-31
20415779 - Scand J Immunol. 2010 Mar;71(3):134-45
19157532 - Lancet. 2009 Feb 21;373(9664):659-72
21801431 - Arthritis Res Ther. 2011;13(4):R126
20682664 - J Rheumatol. 2010 Oct;37(10):2014-20
17641010 - J Immunol. 2007 Aug 1;179(3):1449-57
19479869 - Arthritis Rheum. 2009 Jun;60(6):1647-56
18063670 - Ann Rheum Dis. 2008 Sep;67(9):1299-304
20603592 - Korean J Lab Med. 2010 Jun;30(3):301-6
20583102 - Arthritis Rheum. 2010 Oct;62(10):2876-85
8676080 - J Exp Med. 1996 Jun 1;183(6):2593-603
17763202 - Scand J Rheumatol. 2007 Jul-Aug;36(4):259-64
8485860 - Clin Biochem. 1993 Apr;26(2):75-84
17525752 - Nat Rev Immunol. 2007 Jun;7(6):429-42
9531313 - J Immunol. 1998 Apr 1;160(7):3513-21
21556937 - J Clin Immunol. 2011 Aug;31(4):606-14
22133625 - J Rheumatol. 2012 Jan;39(1):18-21
17375096 - Nat Immunol. 2007 Apr;8(4):345-50
18172584 - Immunol Res. 2008;41(2):87-102
10225978 - J Clin Invest. 1999 May;103(9):1345-52
21056009 - Clin Immunol. 2011 Jan;138(1):107-16
References_xml – volume: 13
  start-page: R126
  year: 2011
  ident: 10.3343/alm.2013.33.1.52_ref15
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3431
– volume: 54
  start-page: 1122
  year: 2006
  ident: 10.3343/alm.2013.33.1.52_ref4
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21749
– volume: 36
  start-page: 259
  year: 2007
  ident: 10.3343/alm.2013.33.1.52_ref16
  publication-title: Scand J Rheumatol
  doi: 10.1080/03009740701286813
– volume: 8
  start-page: 345
  year: 2007
  ident: 10.3343/alm.2013.33.1.52_ref8
  publication-title: Nat Immunol
  doi: 10.1038/ni0407-345
– volume: 373
  start-page: 659
  year: 2009
  ident: 10.3343/alm.2013.33.1.52_ref1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)60008-8
– volume: 31
  start-page: 606
  year: 2011
  ident: 10.3343/alm.2013.33.1.52_ref9
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-011-9540-8
– volume: 138
  start-page: 107
  year: 2011
  ident: 10.3343/alm.2013.33.1.52_ref11
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2010.10.002
– volume: 10
  start-page: R93
  year: 2008
  ident: 10.3343/alm.2013.33.1.52_ref18
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar2477
– volume: 179
  start-page: 1449
  year: 2007
  ident: 10.3343/alm.2013.33.1.52_ref14
  publication-title: J Immunol
  doi: 10.4049/jimmunol.179.3.1449
– volume: 39
  start-page: 18
  year: 2012
  ident: 10.3343/alm.2013.33.1.52_ref21
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.110697
– volume: 41
  start-page: 87
  year: 2008
  ident: 10.3343/alm.2013.33.1.52_ref22
  publication-title: Immunol Res
  doi: 10.1007/s12026-007-8014-9
– volume: 44
  start-page: 2413
  year: 2001
  ident: 10.3343/alm.2013.33.1.52_ref3
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E
– volume: 103
  start-page: 1345
  year: 1999
  ident: 10.3343/alm.2013.33.1.52_ref7
  publication-title: J Clin Invest
  doi: 10.1172/JCI5703
– volume: 71
  start-page: 134
  year: 2010
  ident: 10.3343/alm.2013.33.1.52_ref26
  publication-title: Scand J Immunol
  doi: 10.1111/j.1365-3083.2009.02361.x
– volume: 67
  start-page: 1299
  year: 2008
  ident: 10.3343/alm.2013.33.1.52_ref10
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2007.080341
– volume: 60
  start-page: 1647
  year: 2009
  ident: 10.3343/alm.2013.33.1.52_ref19
  publication-title: Arthritis Rheum
  doi: 10.1002/art.24568
– volume: 7
  start-page: 429
  year: 2007
  ident: 10.3343/alm.2013.33.1.52_ref2
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2094
– volume: 62
  start-page: 2876
  year: 2010
  ident: 10.3343/alm.2013.33.1.52_ref23
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27622
– volume: 38
  start-page: 44
  year: 1995
  ident: 10.3343/alm.2013.33.1.52_ref17
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780380107
– volume: 62
  start-page: 383
  year: 2010
  ident: 10.3343/alm.2013.33.1.52_ref24
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27186
– volume: 26
  start-page: 75
  year: 1993
  ident: 10.3343/alm.2013.33.1.52_ref25
  publication-title: Clin Biochem
  doi: 10.1016/0009-9120(93)90032-2
– volume: 183
  start-page: 2593
  year: 1996
  ident: 10.3343/alm.2013.33.1.52_ref5
  publication-title: J Exp Med
  doi: 10.1084/jem.183.6.2593
– volume: 30
  start-page: 301
  year: 2010
  ident: 10.3343/alm.2013.33.1.52_ref20
  publication-title: Korean J Lab Med
  doi: 10.3343/kjlm.2010.30.3.301
– volume: 37
  start-page: 2014
  year: 2010
  ident: 10.3343/alm.2013.33.1.52_ref12
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.100259
– volume: 8
  start-page: 967
  year: 2007
  ident: 10.3343/alm.2013.33.1.52_ref13
  publication-title: Nat Immunol
  doi: 10.1038/ni1488
– volume: 160
  start-page: 3513
  year: 1998
  ident: 10.3343/alm.2013.33.1.52_ref6
  publication-title: J Immunol
  doi: 10.4049/jimmunol.160.7.3513
– reference: 7818570 - Arthritis Rheum. 1995 Jan;38(1):44-8
– reference: 20682664 - J Rheumatol. 2010 Oct;37(10):2014-20
– reference: 8485860 - Clin Biochem. 1993 Apr;26(2):75-84
– reference: 17763202 - Scand J Rheumatol. 2007 Jul-Aug;36(4):259-64
– reference: 20583102 - Arthritis Rheum. 2010 Oct;62(10):2876-85
– reference: 8676080 - J Exp Med. 1996 Jun 1;183(6):2593-603
– reference: 20415779 - Scand J Immunol. 2010 Mar;71(3):134-45
– reference: 18172584 - Immunol Res. 2008;41(2):87-102
– reference: 21056009 - Clin Immunol. 2011 Jan;138(1):107-16
– reference: 19479869 - Arthritis Rheum. 2009 Jun;60(6):1647-56
– reference: 18710567 - Arthritis Res Ther. 2008;10(4):R93
– reference: 11665984 - Arthritis Rheum. 2001 Oct;44(10):2413-24
– reference: 21801431 - Arthritis Res Ther. 2011;13(4):R126
– reference: 17581537 - Nat Immunol. 2007 Sep;8(9):967-74
– reference: 10225978 - J Clin Invest. 1999 May;103(9):1345-52
– reference: 17641010 - J Immunol. 2007 Aug 1;179(3):1449-57
– reference: 18063670 - Ann Rheum Dis. 2008 Sep;67(9):1299-304
– reference: 9531313 - J Immunol. 1998 Apr 1;160(7):3513-21
– reference: 16572447 - Arthritis Rheum. 2006 Apr;54(4):1122-31
– reference: 17525752 - Nat Rev Immunol. 2007 Jun;7(6):429-42
– reference: 21556937 - J Clin Immunol. 2011 Aug;31(4):606-14
– reference: 17375096 - Nat Immunol. 2007 Apr;8(4):345-50
– reference: 22133625 - J Rheumatol. 2012 Jan;39(1):18-21
– reference: 20603592 - Korean J Lab Med. 2010 Jun;30(3):301-6
– reference: 20112361 - Arthritis Rheum. 2010 Feb;62(2):383-91
– reference: 19157532 - Lancet. 2009 Feb 21;373(9664):659-72
SSID ssj0000601290
Score 2.175689
Snippet Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis (RA). We...
Background: Interleukin-17 (IL-17)-producing T helper (Th) 17 cells are considered as a new subset of cells critical to the development of rheumatoid arthritis...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 52
SubjectTerms Adult
Aged
Arthritis, Rheumatoid - blood
Arthritis, Rheumatoid - metabolism
Arthritis, Rheumatoid - pathology
Blood Sedimentation
C-Reactive Protein - analysis
Cytokines - blood
Female
Humans
Male
Middle Aged
Original
Osteoarthritis - blood
Osteoarthritis - metabolism
Osteoarthritis - pathology
Severity of Illness Index
Th1 Cells - cytology
Th1 Cells - immunology
Th1 Cells - metabolism
Th17 Cells - cytology
Th17 Cells - immunology
Th17 Cells - metabolism
병리학
Title Elevated Levels of T Helper 17 Cells Are Associated with Disease Activity in Patients with Rheumatoid Arthritis
URI https://www.ncbi.nlm.nih.gov/pubmed/23301223
https://www.proquest.com/docview/1273346425
https://pubmed.ncbi.nlm.nih.gov/PMC3535197
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001730163
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Annals of Laboratory Medicine, 2013, 33(1), , pp.52-59
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbYkBAviN-UwWQkXnhIN8d24jwgVI2NgShCaJX6Zl1ie60WJSNtJ_jvuWuSQlHFA0-R40ss-Wzf9_nsO8Ze40DxBqsiyEIaKYremnudR1IbcCKkCLLpcvL4S3I-UZ-mevr7enTXgYud1I7ySU2acvjj-893OOHfEuOUSh5BSVfKhcTSUAw1Lsi30S4lRMXGHdhv1-V-0wVNooqkOe78ljt_QlGCkeuLOJZbJmuvasIuNPr3oco_rNTZfXavg5d81I6HB-yWrx6yO-POgf6I1aelv0F46fhnOi204HXgFxxtz7VvuEj5iS_x5ajxvNcbitJeLX_fenL4qGjzTfB5xb-2QVkXrcS3mV8h_q3njtqfraMlPWaTs9OLk_Ooy7kQFUqLZWRAgfdZlkrQicviNAuQOuOdyRUIpUFKgNwQJs99cAg3IVHOI80qkgQQvjxh-1Vd-WeMK-lSWZhQgA4q8wBBZHCcFUKHAALMgB313WqLLiA55cUoLRIT0olFnVjSCZassDoesDebL67bYBz_kH2FmrJXxdxSBG16Xtb2qrHIEz4i4YkRiKFMr0eLs4pcJVD5erWwAlGdVMjN9IA9bfW6abEfFgOWbml8I0DtbddU89k6crfUlA8xff7fXx6wu_E6HwftAb1g-8tm5V8iKlrmh2zvw1Qcrof8L41YC9c
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+Levels+of+T+Helper+17+Cells+Are+Associated+with+Disease+Activity+in+Patients+with+Rheumatoid+Arthritis&rft.jtitle=Annals+of+laboratory+medicine&rft.au=Kim%2C+Jimyung&rft.au=Kang%2C+Seongwook&rft.au=Kim%2C+Jinhyun&rft.au=Kwon%2C+Gyechul&rft.date=2013-01-01&rft.pub=The+Korean+Society+for+Laboratory+Medicine&rft.issn=2234-3806&rft.eissn=2234-3814&rft.volume=33&rft.issue=1&rft.spage=52&rft.epage=59&rft_id=info:doi/10.3343%2Falm.2013.33.1.52&rft_id=info%3Apmid%2F23301223&rft.externalDocID=PMC3535197
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-3806&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-3806&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-3806&client=summon